Patents by Inventor Gary Kinasewitz

Gary Kinasewitz has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Treatment of sepsis using complement inhibitors
    Patent number: 9358266
    Abstract: Methods for the treatment of sepsis with complement inhibitors are disclosed. In particular, C3 inhibitors, such as Compstatin and Compstatin analogs, are administered at various times following the onset of sepsis to alleviate tissue damage and organ failure, which are hallmarks of the second, extravascular stage of sepsis. Combination therapies for comprehensive treatment of sepsis are also disclosed. Pharmaceutical compositions and kits for use in the methods are disclosed as well.
    Type: Grant
    Filed: February 25, 2011
    Date of Patent: June 7, 2016
    Assignee: The Trustees of the University of Pennsylvania
    Inventors: John D. Lambris, Fletcher B. Taylor, Florea Lupu, Gary Kinasewitz
  • Treatment Of Sepsis Using Complement Inhibitors
    Publication number: 20130053302
    Abstract: Methods for the treatment of sepsis with complement inhibitors are disclosed. In particular, C3 inhibitors, such as Compstatin and Compstatin analogs, are administered at various times following the onset of sepsis to alleviate tissue damage and organ failure, which are hallmarks of the second, extravascular stage of sepsis. Combination therapies for comprehensive treatment of sepsis are also disclosed. Pharmaceutical compositions and kits for use in the methods are disclosed as well.
    Type: Application
    Filed: February 25, 2011
    Publication date: February 28, 2013
    Inventors: John D. Lambris, Fletcher B. Taylor, Florea Lupu, Gary Kinasewitz